MMP9 and stroke disorder: The combination of S100B, B-type neurotrophic growth factor (BNGF), von Willebrand factor (vWF), MMP-9, and monocyte chemotactic protein-1 (MCP-1) provided diagnosis of stroke within 12 h after symptom onset with a 91% sensitivity and a 97% specificity (56).